Chemours (CC) Tops Q3 EPS by 14c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- SanDisk stock rallies on AI optimism and Fed relief
The Chemours Company Reports Third Quarter 2015 Results
November 5, 2015 7:30 AM ESTWILMINGTON, Del., Nov. 5, 2015 /PRNewswire/ --
Third Quarter 2015 Highlights
Net sales of $1.5 billion Adjusted EBITDA of $169 million, a $42 million sequential improvement driven by cost reductions and strong Fluoroproducts performance, partially offset by weak TiO2 environment Adjusted Net Income of $73 million, or $0.40 per diluted share Net loss of $29 million, or a loss of $.16 per diluted share, which included restructuring and impairment costs of $209 million and interest expense of $51 millionOther Highlights
Initiated Five-Point Transformation Plan expected to deliver $500 million Adjusted EBITDA... More